The global Molluscum Contagiosum (MC) Treatment Market is expected to grow significantly from 2018 to 2022, with a continued upward trajectory in demand from 2023 to 2033. Factors such as increasing prevalence of MC, growing awareness and diagnosis rates, availability of advanced treatment options, and high healthcare expenditure are expected to drive market growth during this period. According to a new market research report published by Future Market insights, the global Molluscum Contagiosum (MC) Treatment market is expected to grow at a CAGR of 5% from 2023 to 2033, reaching a market size of USD 4.89 Billion by 2033.
The report highlights that the prevalence of MC is increasing worldwide, with a growing number of cases being reported each year. This is driving the demand for MC treatment, which is expected to continue to rise in the coming years. The report also notes that there is a growing awareness of MC among the general population, leading to more people seeking medical attention for the infection.
Get Latest Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16795
The availability of advanced treatment options is another key factor driving the growth of the MC treatment market. The report highlights that there are a range of treatment options available for MC, including topical creams, cryotherapy, and laser therapy. Key players in the market are investing in research and development to develop new and advanced treatment options, which is driving market growth.
Key Takeaways from the Market Study
- From 2018 to 2022, the Molluscum Contagiosum (MC) Treatment market grew at a CAGR of 3.5%.
- The global Molluscum Contagiosum (MC) Treatment market is expected to grow with a 5% CAGR during 2023 to 2033.
- As of 2033, the Molluscum Contagiosum (MC) Treatment Market is expected to reach US$ 4.89 Billion.
- According to the FMI analysis, surgical treatment accounts for the largest market share.
- North America is expected to possess 40% market share for the Molluscum Contagiosum (MC) Treatment market.
- The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.
“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Molluscum Contagiosum (MC) Treatment.” says an FMI analyst
Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-16795
Market Competition
Key players in the market include companies such as Competition Deep Dive, Novan, Inc., Veloce Biopharma, Gurina Foundation, Azafaros, Polaryx Therapeutics, Abbott Medtronic, Merck & Co., Inc., Pfizer Inc., Siemens Healthcare GmbH, Novartis AG, along with healthcare providers and technology companies among other global players.
- In January 2023, Novan, Inc. announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for berdazimer gel, 10.3% (SB206) for the treatment of molluscum contagiosum. The filing is expected to be reviewed within a typical 12-month period, with a potential approval date in the first quarter of 2024 if accepted. Results from the pivotal Phase 3 B-SIMPLE4 clinical study evaluating berdazimer gel, 10.3% were highly statistically significant and demonstrated improvement in primary clinical endpoint, and the product was found to be well tolerated with mild adverse events reported.
More Insights Available
FMI, in its new offering, presents an unbiased analysis of the global Molluscum Contagiosum (MC) Treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis of type, treatment, end-user & Region.
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16795
Key Segments Profiled in the Molluscum Contagiosum (MC) Treatment Industry Survey
Therapy:
- Cryotherapy
- Curettage
- Immune-modulating Therapies
- Topical Therapies
End-User:
- Hospital
- Skin Clinics
- Immunocompromised Patients
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com